Co-founded by Jennifer Doudna and Fyodor Urnov, the company intends to simultaneously develop many gene editing treatments ...
The hefty funding will fuel Phase 2 testing of a drug with a similar mechanism to Amgen’s closely watched obesity drug, as ...
The financing, which will back a novel type of cancer drug, is the largest of a series of startup fundings announced at the ...
With partner Eli Lilly’s help, the radiopharmaceutical drugmaker priced one of the sector’s largest new stock offerings in the last two years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback